Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Saxagliptin

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 16,016Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Torrent`s Generics Saxagliptin; Dapagliflozin Receives Tentative Approval in US
    Torrent`s Generics Saxagliptin; Dapagliflozin Receives Tentative Approval in US

    19 Sep 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211537

    FDA
    19 Sep 2024
    Share Share
    Dr. Reddy's Announces Launch of Saxagliptin and Metformin Hydrochloride Tablets
    Dr. Reddy's Announces Launch of Saxagliptin and Metformin Hydrochloride Tablets

    10 Aug 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230810716002/en

    BUSINESSWIRE
    10 Aug 2023
    Share Share
    Glenmark gets USFDA nod to market generic diabetes drug
    Glenmark gets USFDA nod to market generic diabetes drug

    01 Aug 2023

    // ECONOMIC TIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/glenmark-gets-usfda-nod-to-market-generic-diabetes-drug/articleshow/102302377.cms

    ECONOMIC TIMES
    01 Aug 2023
    Share Share
    Glenmark gets USFDA nod to market generic diabetes drug
    Glenmark gets USFDA nod to market generic diabetes drug

    01 Jul 2023

    // ECONOMIC TIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/glenmark-gets-usfda-nod-to-market-generic-diabetes-drug/articleshow/102302377.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst

    ECONOMIC TIMES
    01 Jul 2023
    Share Share
    Glenmark gets USFDA nod for generic diabetes drug
    Glenmark gets USFDA nod for generic diabetes drug

    16 Feb 2023

    // ECONOMIC TIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/glenmark-gets-usfda-nod-for-generic-diabetes-drug/articleshow/98003535.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst

    ECONOMIC TIMES
    16 Feb 2023
    Share Share
    Glenmark Pharma gets tentative USFDA nod for generic anti-diabetes tablets
    Glenmark Pharma gets tentative USFDA nod for generic anti-diabetes tablets

    28 Apr 2020

    // ECONOMICTIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/glenmark-pharma-gets-tentative-usfda-nod-for-generic-anti-diabetes-tablets/articleshow/75444093.cms

    ECONOMICTIMES
    28 Apr 2020
    Share Share